BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38567612)

  • 61. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
    Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
    Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
    Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
    J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis and evaluation of Fmoc-amino esters and amides bearing a substrate like quaternary ammonium group as selective butyrylcholinesterase inhibitors.
    Godinez J; Lee CY; Schwans JP
    Bioorg Med Chem Lett; 2023 Aug; 92():129392. PubMed ID: 37364726
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development of quinazolinone and vanillin acrylamide hybrids as multi-target directed ligands against Alzheimer's disease and mechanistic insights into their binding with acetylcholinesterase.
    Yelamanda Rao K; Jeelan Basha S; Monika K; Naidu Gajula N; Sivakumar I; Kumar S; Vadde R; Aramati BMR; Subramanyam R; Damu AG
    J Biomol Struct Dyn; 2023 Dec; 41(20):11148-11165. PubMed ID: 37098803
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles.
    Ozadali-Sari K; Tüylü Küçükkılınç T; Ayazgok B; Balkan A; Unsal-Tan O
    Bioorg Chem; 2017 Jun; 72():208-214. PubMed ID: 28478328
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acetamide Derivatives of Chromen-2-ones as Potent Cholinesterase Inhibitors.
    Prasad S; Kumar B; Kumar S; Chand K; Kamble SS; Gautam HK; Sharma SK
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28699213
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
    Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aqueous extract of Securidaca longipendunculata Oliv. and Olax subscropioidea inhibits key enzymes (acetylcholinesterase and butyrylcholinesterase) linked with Alzheimer's disease in vitro.
    Saliu JA; Olabiyi AA
    Pharm Biol; 2017 Dec; 55(1):252-257. PubMed ID: 27927065
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis of new N-(5,6-methylenedioxybenzothiazole-2-yl)-2-[(substituted)thio/piperazine]acetamide/propanamide derivatives and evaluation of their AChE, BChE, and BACE-1 inhibitory activities.
    Tutuş B; Kaya AZ; Baz Y; Evren AE; Sağlik Özkan BN; Yurttaş L
    Drug Dev Res; 2024 Jun; 85(4):e22214. PubMed ID: 38816986
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Virtual screening of acetylcholinesterase inhibitors using the Lipinski's rule of five and ZINC databank.
    Nogara PA; Saraiva Rde A; Caeran Bueno D; Lissner LJ; Lenz Dalla Corte C; Braga MM; Rosemberg DB; Rocha JB
    Biomed Res Int; 2015; 2015():870389. PubMed ID: 25685814
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
    Duysen EG; Li B; Darvesh S; Lockridge O
    Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
    Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
    Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
    Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Design, Synthesis and Evaluation of Benzimidazole Hybrids to Inhibit Acetylcholinesterase and COX for Treatment of Alzheimer's Disease.
    Kaur S; Minhas R; Mishra S; Kaur B; Bansal Y; Bansal G
    Cent Nerv Syst Agents Med Chem; 2022; 22(1):68-78. PubMed ID: 35899919
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of Alzheimer's disease.
    Brunetti L; Leuci R; Carrieri A; Catto M; Occhineri S; Vinci G; Gambacorta L; Baltrukevich H; Chaves S; Laghezza A; Altomare CD; Tortorella P; Santos MA; Loiodice F; Piemontese L
    Eur J Med Chem; 2022 Jul; 237():114358. PubMed ID: 35462163
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
    Babaee S; Chehardoli G; Akbarzadeh T; Zolfigol MA; Mahdavi M; Rastegari A; Homayouni Moghadam F; Najafi Z
    Chem Biodivers; 2021 Jun; 18(6):e2000924. PubMed ID: 33861892
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chromone derivatives bearing pyridinium moiety as multi-target-directed ligands against Alzheimer's disease.
    Abdpour S; Jalili-Baleh L; Nadri H; Forootanfar H; Bukhari SNA; Ramazani A; Ebrahimi SES; Foroumadi A; Khoobi M
    Bioorg Chem; 2021 May; 110():104750. PubMed ID: 33691251
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Benzimidazole-Carboxamides as Potential Therapeutics for Alzheimer's Disease: Primary Analysis In Silico and In Vitro.
    Chelusnova YV; Voronina PA; Belinskaia DA; Goncharov NV
    Bull Exp Biol Med; 2023 Jul; 175(3):345-352. PubMed ID: 37563531
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors.
    Green KD; Fosso MY; Garneau-Tsodikova S
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544832
    [TBL] [Abstract][Full Text] [Related]  

  • 80. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
    Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
    Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.